Redwood Scientific Technologies Inc
Redwood Scientific Technologies, Inc. develops and markets over-the-counter FDA registered drugs through oral strip delivery technology. The company is based in Claremont, California.
Redwood Scientific Technologies Inc (RSCI) - Total Assets
Latest total assets as of December 2023: $296.47K USD
Based on the latest financial reports, Redwood Scientific Technologies Inc (RSCI) holds total assets worth $296.47K USD as of December 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Redwood Scientific Technologies Inc - Total Assets Trend (2009–2023)
This chart illustrates how Redwood Scientific Technologies Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Redwood Scientific Technologies Inc - Asset Composition Analysis
Current Asset Composition (December 2023)
Redwood Scientific Technologies Inc's total assets of $296.47K consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 91.6% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2009–2023)
This chart illustrates how Redwood Scientific Technologies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Redwood Scientific Technologies Inc's current assets represent 100.0% of total assets in 2023, an increase from 3.6% in 2009.
- Cash Position: Cash and equivalents constituted 91.6% of total assets in 2023, up from 1.8% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 38.0% in 2009.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Redwood Scientific Technologies Inc Competitors by Total Assets
Key competitors of Redwood Scientific Technologies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Redwood Scientific Technologies Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Redwood Scientific Technologies Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Redwood Scientific Technologies Inc is currently not profitable relative to its asset base.
Redwood Scientific Technologies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.60 | 0.57 | 0.09 |
| Quick Ratio | 0.60 | 0.57 | 0.03 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-194.61K | $ -2.03 Million | $ -1.65 Million |
Redwood Scientific Technologies Inc - Advanced Valuation Insights
This section examines the relationship between Redwood Scientific Technologies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | $296.47K |
| Market Capitalization | $2.33K USD |
Valuation Analysis
Below Book Valuation: The market values Redwood Scientific Technologies Inc's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Redwood Scientific Technologies Inc's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Redwood Scientific Technologies Inc (2009–2023)
The table below shows the annual total assets of Redwood Scientific Technologies Inc from 2009 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $296.47K | -- |
| 2022-12-31 | $0.00 | -- |
| 2021-12-31 | $0.00 | -- |
| 2020-12-31 | $0.00 | -- |
| 2017-12-31 | $2.93 Million | +38.84% |
| 2016-12-31 | $2.11 Million | +14184.00% |
| 2015-12-31 | $14.76K | -83.68% |
| 2014-12-31 | $90.43K | -89.50% |
| 2011-12-31 | $860.87K | -3.24% |
| 2010-12-31 | $889.69K | +5.23% |
| 2009-12-31 | $845.50K | -- |